Actinium Pharmaceuticals
ATNM
#10136
Rank
A$44.51 M
Marketcap
A$1.42
Share price
-0.97%
Change (1 day)
-40.97%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -A$58.74 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are A$0.09 Million. In 2024 the company made an earning of -A$60.96 Million, an increase over its 2023 earnings that were of -A$75.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$58.74 Million-3.64%
2024 -A$60.96 Million-18.87%
2023 -A$75.14 Million52.24%
2022 -A$49.36 Million36.61%
2021 -A$36.13 Million11.48%
2020 -A$32.41 Million1.46%
2019 -A$31.95 Million-7.37%
2018 -A$34.49 Million-11.46%
2017 -A$38.95 Million10.67%
2016 -A$35.2 Million15.7%
2015 -A$30.42 Million-14.86%
2014 -A$35.73 Million129.19%
2013 -A$15.59 Million-8.55%
2012 -A$17.05 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.04 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-A$53.83 Million-0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.27 M-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.69 B-1,392.20%๐Ÿ‡บ๐Ÿ‡ธ USA